Nanoplatforms for Cancer Theranostics

SEP 9, 2026 · JOURNAL ARTICLE

Extracellular vesicles for next-gen therapeutics and drug delivery

Molecular Biomedicine

A comprehensive narrative review synthesizing the biology, engineering, and therapeutic potential of extracellular vesicles, offering expert perspective on current state and future directions rather than reporting original experimental results.

SEP 9, 2026 · JOURNAL ARTICLE

A Manganese-Chlorella Hydrogel for an Integrated “Remove–Remodel–Repair” Strategy in Pancreatic Cancer Therapy

Nano-micro Letters

This is a preclinical proof-of-concept study of a novel hydrogel material tested in vitro and in animal models, demonstrating feasibility but lacking human clinical data or comparison to standard therapy.

SEP 8, 2026 · JOURNAL ARTICLE

Tumor‐Adhesive Ru/Ca‐Tannic Acid Network Enables Phosphate‐Independent Calcification and Photothermal‐Synergistic Therapy for Osteolytic Bone Metastasis

Small

Preclinical proof-of-concept in a murine model with no clinical data, surrogate endpoints (tumor burden, bone destruction markers), and no human efficacy or safety evidence.

SEP 8, 2026 · JOURNAL ARTICLE

Rational Design of a Smart Phototheranostic Nanoagent Based on a NIR-II-Conjugated Polymer for Highly Tumor-Specific Multimodal Imaging-Guided Synergistic Therapy

Acs Applied Materials & Interfaces

This is a preclinical materials science study reporting rational design and in vitro/in vivo characterization of a nanoagent; it raises mechanistic questions about nanoparticle performance but does not test efficacy against a comparator in any clinical or disease model.

SEP 8, 2026 · JOURNAL ARTICLE

Sequential Precise Targeted Hepatitis B Virus Therapy: Hepatitis B Virus-Specific Small Interfering RNA Followed by Aggregation-Induced Emission-Photothermal Ablation Based on Macrophage Membrane-Coated Nanoplatform

Acs Applied Bio Materials

This is an exploratory in vitro proof-of-concept study of a novel nanoplatform combining siRNA and photothermal therapy; it demonstrates mechanism in cell models but lacks in vivo efficacy data, clinical translation, or direct comparison to standard antiviral therapy.

SEP 8, 2026 · JOURNAL ARTICLE

Targeted Strategies for Treatment of Colorectal Cancer: Exploring the Use of Aptamers and Gold Nanoparticles

Molecules

This is a narrative review exploring preclinical aptamer and gold nanoparticle strategies for colorectal cancer, presenting mechanistic concepts and projected benefits without clinical trial data or empirical validation.

SEP 8, 2026 · JOURNAL ARTICLE

Bufalin-Loaded Multifunctional Nanodrugs for Cancer Therapy: Mechanisms, Delivery Strategies, and Translational Perspectives

Biomolecules

This is a narrative review synthesizing preclinical mechanistic evidence and nanocarrier design strategies for bufalin, with no clinical trials, efficacy data, or comparative outcomes reported.

SEP 7, 2026 · JOURNAL ARTICLE

Sprayable hydrogel loaded with engineered fusion cellular vesicles for cancer recurrence suppression

Journal of Nanobiotechnology

Preclinical proof-of-concept in engineered cellular vesicles and mouse tumor models; no human data, no efficacy endpoint with confidence intervals or statistical comparison, and no toxicity data reported.